INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Indivior Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$33.87+1.42 (+4.38%)
Close on Oct 19, 2026
- Market cap
- $4.20B
- P/E (TTM)
- 12.2
- Dividend yield
- –
SEC filings
40 of Indivior Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2026 | Oct 6, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 17, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | May 13, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 23, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 22, 2025 | Dec 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 15, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2025 | Nov 20, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 1, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2025 | Aug 26, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2025 | Aug 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 24, 2025 | SEC EDGAR |
| Current report | 8-K | May 30, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 24, 2025 | Apr 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |